jRCT2031250655
招募中
不适用
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Dose of MK-8507 and Multiple Once Weekly Dose of Islatravir/MK-8507 (MK-8591B) in Healthy Japanese Participants
未提供0 个研究点目标入组 24 人开始时间: 待定
概览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 24
概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 18age old over 至 55age old under（—）
- 性别
- All
入选标准
- •Healthy male and female participants between the ages of 18 and 55 years
排除标准
- •Has a history of clinically significant abnormalities or diseases
研究者
相似试验
尚未招募
1 期
A clinical study to investigate the safety, tolerability and pharmacokinetic profile of single ascending concentrations of OPT101 in peritoneal dialysis patients.2025-522966-61-00OPTERION Health AG12
招募中
1/2 期
Clinical study to evaluate the safety and tolerability of SPVN06 (novel gene therapy) in a subset of patients with rod cone dystrophy (RCD).2022-501250-12-01Sparingvision17
招募中
1 期
A study investigating the safety, tolerability, metabolism, and elimination of INE963, a new compound in the treatment of malaria.2024-516911-26-00Novartis Pharma AG94
撤回
1 期
A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a pDNA Vaccine Candidate Against COVID-19 in Healthy Adults2023-505135-12-00Imam Abdulrahman Bin Faisal University60
招募中
1 期
A Phase 1 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Denikitug (GS-1811), an Afucosylated Anti-CCR8 Monoclonal Antibody, as Monotherapy and in Combination With an Anti–PD-1 Monoclonal Antibody in Adults With Advanced Solid Tumors2022-501684-40-00Gilead Sciences Inc.93